Contineum Therapeutics, Inc.CTNMEarnings & Financial Report

Nasdaq · Health Care · Pharmaceutical Preparations

Deep AnalysisCompare

Contineum Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing first-in-class and best-in-class targeted therapies to address unmet medical needs in autoimmune, inflammatory, and fibrotic diseases. It operates across North American and global biotech research networks, advancing multiple pipeline candidates through early to mid-stage clinical trials.